News Focus
News Focus
icon url

TheDane

10/23/14 10:57 PM

#74959 RE: alexwv #74958

Chasing? It only went up .19. I'm wondering if the small increase might lead some to think time is on their side.

Maybe. Maybe not. Choosing is always the hardest part.

Go CTIX!
icon url

frrol

10/24/14 8:29 AM

#74997 RE: alexwv #74958

Company management is not sending any message. They are disclosing positive test results as soon as they can to keep shareholders informed and the stock price up, since they are funding with equity.

Yesterday they made a change to executive management and are required by the SEC to publicly disclose such information as soon as it is legally effective. This is because the equity shares are registered with the Commission. The company is effectively a fully-reporting entity, which btw will make the exchange listing much easier.

Management does not give two hoots about any message-board, "fence sitters/flippers/shorts" or any other silliness. They're building a development stage pharma company, developing therapies and designing trials.
icon url

TOB

10/24/14 9:30 AM

#75013 RE: alexwv #74958

CTIX is an OTC stock under $5. There are very few shorts and many brokerage houses don't even permit shorting.

Leo sent a very,very clear message to fence sitters/flippers/shorts that you never know when news will be released from here on out! I wonder how many got caught playing games and are now chasing the stock. I hope they have their best running shoes on! Expect the shorts to cover tomorrow if they have any sense left. -alexwv



Shorting won't become common until after uplisting and a higher share price. They will be welcome as they provide more liquidity and mean CTIX is trading much higher.

The CTIX CEO Leo Ehrlich is a brilliant man who is obviously highly focused on developing Cellceutix. The amazingly rapid progress with Brilacidin the number of clinical trials demonstrate this. I highly doubt he spends even a second thinking about "fence sitters/flippers/shorts" or martians. He's busy building value for CTIX shareholders.